Monday, March 26, 2018

JenaValve Names New Board Member

Irvine-based JenaValve, which develops replacement heart valves to treat aortic valve disease, announced on Friday that it has named Keith D. Dawkins, M.D., as a new JenaValve board member. Dr. Dawkins is currently Chief Medical Officer of 4Tech, INc., and previously was Executive Vice President and Global Chief Medical Officer at Boston Scientific, and also had been Senior Vice President and CMO for the Boston Scientific Cardiology Rhythm and Vascular Group. Dawkins spent more than 20 years in the UK as a practicing interventional cardiologist prior to his time in the medical device industry.